Clinical Trial Update: Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of aripiprazole for psychosis associated with Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Psychosis

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Parkinson's Disease, Psychoses | Phase 4 | Status: COMPLETED